UV Device Confusion: Why Hospitals Must Ask the Right Regulatory Questions
In Part 3 of Infection Control Today’s exclusive interview with Gunner Lyslo, CEO of Surfacide, the discussion turns to one of the most pressing issues in hospital infection prevention—understanding the regulatory requirements for UV-C devices.
While many facilities are eager to adopt UV-C technology to reduce health care-associated infections (HAIs), the reality is that not all devices are created—or regulated—equally. Lyslo explains how gaps in awareness can lead to costly noncompliance and potentially compromise patient safety.
Hospitals must ask the right questions before purchasing:
- Is the device cleared or authorized by the FDA for its intended medical use?
- Does it meet the latest Whole Room Microbial Reduction standards?
- How does it align with infection prevention protocols and staff training requirements?
By shedding light on these regulatory nuances, Lyslo empowers infection prevention and control (IPC) professionals to make informed decisions that protect both patients and the institution.
Watch Part 3 to learn how to navigate the complexities of UV-C device compliance and safeguard your facility’s infection prevention goals.
